Suwabe A, Ito M, Takahashi K
Department of Laboratory Medicine, Yamagata University School of Medicine.
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Oct;34(10):1104-8.
Effects of erythromycin on surfactant synthesis, secretion, and recycling by rat alveolar type II cells were examined. Type II cells were isolated from rat lungs and incubated with 3H-choline, a precursor of surfactant. Synthesis was quantified from the amount of 3H-phosphatidylcholine and from the distribution to lamellar body fractions as measured with sucrose density gradients. Secretion was quantified from the percent of synthesized 3H-phosphatidylcholine released into the medium over 3 hr. Recycling was quantified from the percent uptake over 1 h of 3H-labeled synthetic liposomes. Type II cells incubated with erythromycin (5-50 micrograms/ml) for 22 hrs secreted less surfactant in response to PMA and ATP than did control cells. Erythromycin did not affect synthesis or recycling of surfactant by type II cells. These results show that erythromycin inhibits surfactant secretion from type II cells, and suggest that erythromycin may be effective in surfactant-excess states such as alveolar proteinosis.
研究了红霉素对大鼠肺泡Ⅱ型细胞表面活性物质合成、分泌及再循环的影响。从大鼠肺中分离出Ⅱ型细胞,并用表面活性物质的前体3H-胆碱进行孵育。通过3H-磷脂酰胆碱的量以及用蔗糖密度梯度测量的向板层小体组分的分布来定量合成。通过在3小时内释放到培养基中的合成3H-磷脂酰胆碱的百分比来定量分泌。通过3H标记的合成脂质体在1小时内的摄取百分比来定量再循环。与对照细胞相比,用红霉素(5-50微克/毫升)孵育22小时的Ⅱ型细胞对佛波酯和ATP的反应分泌的表面活性物质较少。红霉素不影响Ⅱ型细胞表面活性物质的合成或再循环。这些结果表明,红霉素抑制Ⅱ型细胞表面活性物质的分泌,并提示红霉素可能对表面活性物质过多的状态如肺泡蛋白沉着症有效。